BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10394841)

  • 1. Administration of fluconazole in children below 1 year of age.
    Schwarze R; Penk A; Pittrow L
    Mycoses; 1999 Apr; 42(1-2):3-16. PubMed ID: 10394841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of fluconazole in children less than 1 year old: review].
    Schwarze R; Penk A; Pittrow L
    Mycoses; 1998; 41 Suppl 1():61-70. PubMed ID: 9717389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and safety of fluconazole and micafungin in neonates with systemic candidiasis: a randomized, open-label clinical trial.
    Leroux S; Jacqz-Aigrain E; Elie V; Legrand F; Barin-Le Guellec C; Aurich B; Biran V; Dusang B; Goudjil S; Coopman S; Garcia Sanchez R; Zhao W; Manzoni P;
    Br J Clin Pharmacol; 2018 Sep; 84(9):1989-1999. PubMed ID: 29744900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of high dosage fluconazole in therapy of candida infections in intensive care medicine].
    Duswald KH; Pittrow L; Penk A
    Anaesthesiol Reanim; 1998; 23(5):134-8. PubMed ID: 9854332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of candidal infections with fluconazole in neonates and infants.
    Schwarze R; Penk A; Pittrow L
    Eur J Med Res; 2000 May; 5(5):203-8. PubMed ID: 10806122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosage adjustment of fluconazole during continuous renal replacement therapy (CAVH, CVVH, CAVHD, CVVHD).
    Pittrow L; Penk A
    Mycoses; 1999 Apr; 42(1-2):17-9. PubMed ID: 10394842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.
    Debruyne D
    Clin Pharmacokinet; 1997 Jul; 33(1):52-77. PubMed ID: 9250423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of oral fluconazole in premature infants.
    Wenzl TG; Schefels J; Hörnchen H; Skopnik H
    Eur J Pediatr; 1998 Aug; 157(8):661-2. PubMed ID: 9727851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
    Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
    Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose therapy with fluconazole > or = 800 mg day-1.
    Duswald KH; Penk A; Pittrow L
    Mycoses; 1997 Nov; 40(7-8):267-77. PubMed ID: 9476509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of fluconazole in liver transplantation: implications for target attainment for infections with Candida albicans and non-albicans spp.
    Cojutti PG; Lugano M; Righi E; Della Rocca G; Bassetti M; Hope W; Pea F
    Eur J Clin Pharmacol; 2018 Nov; 74(11):1449-1459. PubMed ID: 30032414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new pharmaceutical concept for the treatment of oropharyngeal and oesophageal candidosis with fluconazole.
    Wildfeuer A; Laufen H; Yeates RA; Zimmermann T
    Mycoses; 1996; 39(9-10):357-60. PubMed ID: 9009658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new pharmaceutical concept for the therapy of oropharyngeal and esophageal candidiasis with fluconazole].
    Wildfeuer A; Laufen H; Yeates RA; Zimmermann T
    Mycoses; 1996; 39 Suppl 1():123-6. PubMed ID: 8767284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [High-dose therapy with fluconazole > or = 800 mg/day. Review].
    Penk A; Pittrow L
    Mycoses; 1997; 40 Suppl 1():33-42. PubMed ID: 9417511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of fluconazole in children requiring peritoneal dialysis.
    Wong SF; Leung MP; Chan MY
    Clin Ther; 1997; 19(5):1039-47. PubMed ID: 9385491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and safety of fluconazole in young infants supported with extracorporeal membrane oxygenation.
    Watt KM; Benjamin DK; Cheifetz IM; Moorthy G; Wade KC; Smith PB; Brouwer KL; Capparelli EV; Cohen-Wolkowiez M
    Pediatr Infect Dis J; 2012 Oct; 31(10):1042-7. PubMed ID: 22627870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Level of evidence for therapeutic drug monitoring of fluconazole].
    Venisse N; Le Guellec C
    Therapie; 2011; 66(2):97-101. PubMed ID: 21635855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungals in systemic neonatal candidiasis.
    Frattarelli DA; Reed MD; Giacoia GP; Aranda JV
    Drugs; 2004; 64(9):949-68. PubMed ID: 15101785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluconazole loading dose pharmacokinetics and safety in infants.
    Piper L; Smith PB; Hornik CP; Cheifetz IM; Barrett JS; Moorthy G; Hope WW; Wade KC; Cohen-Wolkowiez M; Benjamin DK
    Pediatr Infect Dis J; 2011 May; 30(5):375-8. PubMed ID: 21085048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
    Charlier C; Hart E; Lefort A; Ribaud P; Dromer F; Denning DW; Lortholary O
    J Antimicrob Chemother; 2006 Mar; 57(3):384-410. PubMed ID: 16449304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.